Fuse Science (DROP) Stock Price
Fuse Science Price
Revenue at Fuse Science has contracted by 10.5% per year over the past 18 years to 448,600.00 USD. Fuse Science's net margin stands at -1,715.5%, down from -383.3% several years earlier. The stock trades about 322% above its 52-week low.
Fuse Science stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Fuse Science over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Fuse Science stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Fuse Science's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Fuse Science Price |
|---|---|
| 9/2/2026 | 0.01 USD |
| 9/1/2026 | 0.01 USD |
| 8/31/2026 | 0.01 USD |
| 8/30/2026 | 0.01 USD |
| 8/28/2026 | 0.01 USD |
| 8/27/2026 | 0.01 USD |
| 8/26/2026 | 0.01 USD |
| 8/25/2026 | 0.01 USD |
| 8/24/2026 | 0.01 USD |
| 8/21/2026 | 0.01 USD |
| 8/20/2026 | 0.01 USD |
| 8/19/2026 | 0.01 USD |
| 8/18/2026 | 0.01 USD |
| 8/17/2026 | 0.01 USD |
| 8/14/2026 | 0.02 USD |
| 8/13/2026 | 0.01 USD |
| 8/12/2026 | 0.02 USD |
| 8/11/2026 | 0.02 USD |
| 8/10/2026 | 0.01 USD |
| 8/7/2026 | 0.01 USD |
| 8/6/2026 | 0.01 USD |
| 8/5/2026 | 0.01 USD |
| 8/4/2026 | 0.01 USD |
| 8/3/2026 | 0.01 USD |
| 7/30/2026 | 0.01 USD |
| 7/29/2026 | 0.01 USD |
| 7/28/2026 | 0.01 USD |
| 7/27/2026 | 0.01 USD |
| 7/24/2026 | 0.00 USD |
| 7/23/2026 | 0.00 USD |
Fuse Science Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Fuse Science Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 3.00 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| – | 166.67 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| – | – | – | – | – | – | – | – | – | – | – | -1.00 | -7.00 | -8.00 | -5.00 | -4.00 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| -6.00 | – | -1.00 | – | – | – | – | – | – | – | – | -2.00 | -11.00 | -21.00 | -7.00 | -24.00 |
| – | – | – | – | – | – | – | – | – | – | – | – | 450.00 | 90.91 | -66.67 | 242.86 |
| 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 0.02 | 0.03 | 0.03 | 0.03 | 0.06 | 0.13 | 0.23 | 80.00 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Fuse Science generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Fuse Science retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Fuse Science's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Fuse Science has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Fuse Science's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Fuse Science stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Fuse Science Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Fuse Science business model & stock analysis
Fuse Science SWOT Analysis
Strengths
[ { "heading": "1.", "text": "Innovative" } ]
Fuse Science Inc is equipped with a unique and innovative product line, offering cutting-edge solutions in the field of nutrition and energy. This product differentiation allows the company to stand out among its competitors.
[ { "heading": "2.", "text": "Strong" } ]
Fuse Science Inc has successfully built a strong brand presence in the market, gaining recognition and trust from consumers. This recognition provides a competitive advantage by attracting loyal customers.
[ { "heading": "3.", "text": "Strategic" } ]
The company has established strategic partnerships with well-known athletes and sports organizations, enabling them to leverage their brand image and expand their reach. These partnerships contribute to the overall growth and credibility of Fuse Science Inc.
Weaknesses
[ { "heading": "1.", "text": "Limited" } ]
Fuse Science Inc faces challenges in penetrating new markets due to limited resources and market awareness. This restricts their ability to reach a larger customer base and potentially hampers business growth.
[ { "heading": "2.", "text": "Dependency" } ]
The company's success heavily relies on its strategic partnerships. Any negative developments or terminations in these partnerships could severely impact Fuse Science Inc's operations and brand reputation.
[ { "heading": "3.", "text": "Regulatory" } ]
Operating in the health and nutrition industry requires strict adherence to regulatory guidelines. Failure to comply with these regulations can lead to legal and reputation-related challenges for the company.
Opportunities
[ { "heading": "1.", "text": "Growing" } ]
The health and fitness market is experiencing significant growth, with consumers increasingly prioritizing self-care and wellness. Fuse Science Inc can capitalize on this trend by expanding its product offerings and targeting health-conscious demographics.
[ { "heading": "2.", "text": "Online" } ]
The rise of e-commerce provides an opportunity for Fuse Science Inc to enhance its online sales and marketing efforts. A strong online presence, coupled with effective digital marketing strategies, can help the company reach a wider audience and increase sales.
[ { "heading": "3.", "text": "Product" } ]
Continued investment in research and development can lead to the creation of new and improved products, allowing Fuse Science Inc to stay ahead of the competition. Innovation will enable the company to capture market share and satisfy evolving customer needs.
Threats
[ { "heading": "1.", "text": "Intense" } ]
The health and nutrition industry is highly competitive, with numerous established players and new entrants. Fuse Science Inc faces the challenge of keeping up with competitor offerings and maintaining market share.
[ { "heading": "2.", "text": "Economic" } ]
Fluctuations in the overall economy, such as recessions or downturns, can have an adverse impact on consumer spending and priorities. This can potentially affect the demand and sales of Fuse Science Inc's products.
[ { "heading": "3.", "text": "Negative" } ]
Any negative publicity or scandals related to the health and nutrition industry can tarnish the brand image and reputation of Fuse Science Inc. Maintaining a positive perception and addressing any potential issues is crucial in mitigating this threat.
Fuse Science Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Fuse Science historical P/E ratio, EBIT multiple, and P/S ratio
Fuse Science annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Fuse Science shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Fuse Science stock splits
Fuse Science Executives and Management Board
38 members · avg. age 51 · 11 % women
Aitan Zacharin
Chief Information Officer, Chief Marketing Officer, Director · since 2011
291,300.00 USD
Management
Brian Tuffin (47)
Chief Executive Officer, Acting Chief Financial Officer, Director · since 2011
Christopher Baker (43)
President and Chief Operating Officer · since 1999
Adam Adler
Vice President - Business Development, Director · since 2011
Robbie Efird (43)
Chairman of the Board, Chief Executive Officer · since 1999
Jeanne Hebert (44)
Senior Vice President - Marketing and Clinical Research, Corporate Secretary · since 2014
Edgar Miller (64)
Senior Vice President of Sales and Marketing and Director
Board of Directors
Mr. G. Anthony Munno (49)
Director · since 2000
Dr. Gelvin Stevenson (70)
Independent Director · since 2014
Reginald Hollinger (50)
Independent Director · since 2013
Dr. Richard Hutchings (56)
Director · since 2011
Dr. David Berkoff (42)
Director · since 2011
Ms. JoAnne Brandes (55)
Independent Director · since 2013
Frequently asked questions about Fuse Science
The business model of Fuse Science Inc. revolves around innovative consumer healthcare products. Fuse Science creates and markets unique delivery systems for active lifestyle supplements, pharmaceuticals, and over-the-counter medications. The company focuses on enhancing the uptake and bioavailability of its products through cutting-edge technology and proprietary formulas. With a strong emphasis on research and development, Fuse Science aims to provide convenient and effective solutions to consumers, supporting their overall health and performance. Fuse Science Inc. is committed to delivering high-quality products and expanding its market presence in the ever-growing wellness industry.
Fuse Science Inc is primarily active in the industries of pharmaceuticals and health sciences.
The main competitors of Fuse Science Inc in the market are companies such as Nike, Inc., Gatorade, Under Armour, LifeVantage Corporation, and Nature's Sunshine Products, Inc.
Fuse Science Inc is a prominent company focused on the development of innovative consumer products across various industries. With a rich history and background, Fuse Science has successfully positioned itself as a leader in the market. The company has a strong commitment to research and development, consistently introducing groundbreaking solutions and cutting-edge technologies. Fuse Science Inc has established strategic partnerships and collaborations with key industry players, further enhancing its market presence. With a relentless pursuit of excellence, Fuse Science continues to pave the way for advancements in various sectors, delivering value to its customers and generating growth opportunities globally.
Fuse Science Inc has achieved several significant milestones in its history. The company successfully launched their innovative technologies, including Fuse Science PowerFuse and EnerJel, which have garnered widespread attention and adoption in the sports and wellness industry. Fuse Science Inc has also formed strategic partnerships with prominent athletes and sports organizations, further enhancing its brand recognition and market presence. Additionally, the company has expanded its product portfolio to include Fuse Science ElectroFuse, a revolutionary electrolyte replacement solution. These achievements demonstrate Fuse Science Inc's commitment to pioneering breakthrough products and its continued growth in the market.
Fuse Science Inc primarily operates in the United States.
Fuse Science Inc represents values of innovation, excellence, and advancement in the realm of health and performance. With a corporate philosophy focused on developing and commercializing innovative consumer products, Fuse Science aims to enhance the lives of individuals by providing cutting-edge solutions. Known for its proprietary delivery system, Fuse Science stands at the forefront of topical and systemic health and wellness technologies. This Florida-based company strives to revolutionize the way people consume, absorb, and utilize important nutrients and compounds, ultimately leading to improved overall well-being and performance. Fuse Science Inc continually pushes boundaries and embraces new possibilities in its commitment to driving positive transformation in the health and wellness industry.
Converted at the current exchange rate, the Fuse Science share trades at 0.01 EUR (0.01 USD).
Fuse Science Inc. is a US-based company that focuses on the development and marketing of innovative products in the field of sports nutrition and wellness. The company's business model is based on the development of patented technologies that allow it to develop highly effective and fast-acting products specifically tailored to the needs of athletes and fitness enthusiasts. Fuse Science believes that the combination of innovative technologies and targeted marketing strategies gives the company a competitive advantage over its competitors. Fuse Science has three main business segments: Sports Nutrition, Medical Devices, and Scientific Research. Each of these segments has the potential to drive the company's growth. In the field of sports nutrition, Fuse Science offers a wide range of products specifically designed for athletes and fitness enthusiasts. These products include energy drinks, protein shakes, dietary supplements, and more. Fuse Science has patented technologies that allow the company to quickly bring to market fast-acting products that provide the body with immediate energy, nutrients, and other essential ingredients. This is a crucial competitive advantage over competitors who are unable to respond as quickly to market changes. In the field of medical devices, Fuse Science has developed products that help alleviate pain and inflammation in sports injuries and arthritis. These products are based on patented technologies and are able to treat the affected area specifically. In particular, the product EnerJel, a pain reliever in gel form, has proven to be very successful. Fuse Science is always working on further developing its products and technologies to meet the needs of its customers. In the field of scientific research, Fuse Science continuously conducts research and development to optimize the performance of its products. Fuse Science works closely with renowned scientists to develop new technologies and products. This way, the company can ensure that its products are always state-of-the-art and provide customers with a crucial advantage in the field of sports nutrition and medical devices. In addition to its business segments, Fuse Science also offers various services, such as consulting for athletes and trainers. Fuse Science has built a strong network of professionals with extensive experience in the field of sports nutrition and medicine. These experts are available to Fuse Science's customers to advise them on selecting the right products and on their application and dosage. Fuse Science has built a strong foundation and is on track to become a leading company in the field of sports nutrition and medical devices. The patented technology and strong network of professionals will enable Fuse Science to continue offering innovative products and services in the future.
The revenue cannot currently be calculated for Fuse Science.
The profit cannot currently be calculated for Fuse Science.
The P/E ratio cannot be calculated for Fuse Science at the moment.
The P/S cannot be calculated for Fuse Science currently.
The Eulerpool Quality Score for Fuse Science is 2/10.
The ISIN of Fuse Science is US36113J3041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Fuse Science is DROP. The ticker symbol is used to trade Fuse Science shares on the stock exchange.
Fuse Science paid dividends every year for the past 0 years.
Fuse Science is assigned to the 'Non-cyclical consumption' sector.
The dividends of Fuse Science are distributed in USD.
Fuse Science stock
Fuse Science Peer Group
Fuse Science FIGI
All fundamentals and in-depth analysis of Fuse Science
Our stock analysis for Fuse Science stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuse Science. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.